An inflammatory environment containing TNF alpha favors Tet2-mutant clonal hematopoiesis
Top Cited Papers
- 28 February 2018
- journal article
- research article
- Published by Elsevier BV in Experimental Hematology
- Vol. 59, 60-65
- https://doi.org/10.1016/j.exphem.2017.11.002
Abstract
No abstract availableKeywords
Funding Information
- Queen's University
- Canada Foundation for Innovation
- Ontario Institute for Cancer Research
- Southeastern Ontario Academic Medical Organization
- Women's Giving Circle/University Hospitals Kingston Foundation
This publication has 23 references indexed in Scilit:
- DNMT3A and TET2 dominate clonal hematopoiesis and demonstrate benign phenotypes and different genetic predispositionsBlood, 2017
- Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderlyBlood, 2017
- Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA SequenceNew England Journal of Medicine, 2014
- Age-Related Clonal Hematopoiesis Associated with Adverse OutcomesNew England Journal of Medicine, 2014
- Clinical and biological implications of driver mutations in myelodysplastic syndromesBlood, 2013
- Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignanciesBlood, 2011
- TET2 Inactivation Results in Pleiotropic Hematopoietic Abnormalities in Mouse and Is a Recurrent Event during Human LymphomagenesisCancer Cell, 2011
- Tet2 Loss Leads to Increased Hematopoietic Stem Cell Self-Renewal and Myeloid TransformationCancer Cell, 2011
- Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2Nature, 2010
- Mutation inTET2in Myeloid CancersNew England Journal of Medicine, 2009